nach oben

NeuroMolecular Medicine

Erschienen in:

01.12.2010 | Review Paper

The Role of the Ceramide Acyl Chain Length in Neurodegeneration: Involvement of Ceramide Synthases

verfasst von: Oshrit Ben-David, Anthony H. Futerman

Erschienen in: NeuroMolecular Medicine | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Ceramide forms the backbone of all complex sphingolipids and has been the focus of considerable attention in the past few years due to the discovery that ceramide plays vital roles as an intracellular messenger. Ceramide, which consists of a sphingoid long chain base to which a fatty acid is N-acylated, is synthesized in mammals by a family of ceramide synthases (CerS), each of which uses a restricted subset of fatty acyl CoAs for N-acylation. Sphingolipids are found at high levels in nervous tissue, where they perform a variety of important functions in both the adult and the maturing brain. We now review what is known about the role of the acyl chain composition of ceramides and sphingolipids in normal brain development and in neurological diseases. Specifically, we attempt to integrate the information that is available about CerS expression and activity in the brain with the changes in the acyl chain composition of ceramide and complex sphingolipids in a number of neurodegenerative diseases and conditions, such as metachromatic leukodystrophy, neuronal ceroid lipofuscinoses, HIV infection, aging, Alzheimer’s disease, ischemia, and epilepsy. We conclude that understanding the direct relationship between the CerS proteins and neurological conditions will be of great importance for delineating the precise roles of sphingolipids in the brain and is likely to be the subject of intense research activity in the years ahead.

Adibhatla, R. M., & Hatcher, J. F. (2008). Altered lipid metabolism in brain injury and disorders. SubCellular Biochemistry, 49, 241–268.CrossRefPubMed

Arboleda, G., Morales, L. C., Benitez, B., & Arboleda, H. (2009). Regulation of ceramide-induced neuronal death: Cell metabolism meets neurodegeneration. Brain Research Reviews, 59, 333–346.CrossRefPubMed

Baran, Y., Salas, A., Senkal, C. E., Gunduz, U., Bielawski, J., Obeid, L. M., et al. (2007). Alterations of ceramide/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells. The Journal of Biological Chemistry, 282, 10922–10934.CrossRefPubMed

Baumann, N., & Pham-Dinh, D. (2001). Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiological Reviews, 81, 871–927.PubMed

Becker, I., Wang-Eckhardt, L., Yaghootfam, A., Gieselmann, V., & Eckhardt, M. (2008). Differential expression of (dihydro)ceramide synthases in mouse brain: Oligodendrocyte-specific expression of CerS2/Lass2. Histochemistry and Cell Biology, 129, 233–241.CrossRefPubMed

Bengtsson, H., Epifantseva, I., Abrink, M., Kylberg, A., Kullander, K., Ebendal, T., et al. (2008). Generation and characterization of a Gdf1 conditional null allele. Genesis, 46, 368–372.CrossRefPubMed

Boldin, S., & Futerman, A. H. (1997). Glucosylceramide synthesis is required for basic fibroblast growth factor and laminin to stimulate axonal growth. Journal of Neurochemistry, 68, 882–885.CrossRefPubMed

Boldin, S. A., & Futerman, A. H. (2000). Up-regulation of glucosylceramide synthesis upon stimulation of axonal growth by basic fibroblast growth factor. Evidence for post- translational modification of glucosylceramide synthase. The Journal of Biological Chemistry, 275, 9905–9909.CrossRefPubMed

Brann, A., Scott, R., Neuberger, Y., Abulafia, D., Boldin, S., Fainzilber, M., et al. (1999). Ceramide signaling downstream of the p75 neurotrophin receptor mediates the effects of nerve growth factor on outgrowth of cultured hippocampal neurons. Journal of Neuroscience, 19, 8199–8206.PubMed

Brann, A. B., Tcherpakov, M., Williams, I. M., Futerman, A. H., & Fainzilber, M. (2002). NGF-induced p75-mediated death of cultured hippocampal neurons is age-dependent and transduced through ceramide generated by neutral sphingomyelinase. The Journal of Biological Chemistry, 277, 9812–9818.CrossRefPubMed

Buccoliero, R., & Futerman, A. H. (2003). The roles of ceramide and complex sphingolipids in neuronal cell function. Pharmacological Research, 47, 409–419.CrossRefPubMed

Cutler, R. G., Haughey, N. J., Tammara, A., McArthur, J. C., Nath, A., Reid, R., et al. (2004a). Dysregulation of sphingolipid and sterol metabolism by ApoE4 in HIV dementia. Neurology, 63, 626–630.PubMed

Cutler, R. G., Kelly, J., Storie, K., Pedersen, W. A., Tammara, A., Hatanpaa, K., et al. (2004b). Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer’s disease. Proceedings of the National Academy of Sciences of the United States of America, 101, 2070–2075.CrossRefPubMed

Eckhardt, M., Hedayati, K. K., Pitsch, J., Lullmann-Rauch, R., Beck, H., Fewou, S. N., et al. (2007). Sulfatide storage in neurons causes hyperexcitability and axonal degeneration in a mouse model of metachromatic leukodystrophy. Journal of Neuroscience, 27, 9009–9021.CrossRefPubMed

Erez-Roman, R., Pienik, R., & Futerman, A. H. (2010). Increased ceramide synthase 2 and 6 mRNA levels in breast cancer tissues and correlation with sphingosine kinase expression. Biochemical and Biophysical Research Communications, 391, 219–223.CrossRefPubMed

Futerman, A. H., & Hannun, Y. A. (2004). The complex life of simple sphingolipids. EMBO Reports, 5, 777–782.CrossRefPubMed

Gautheron, V., Auffret, A., Mattson, M. P., Mariani, J., & Vernet-der Garabedian, B. (2009). A new and simple approach for genotyping Alzheimer’s disease presenilin-1 mutant knock-in mice. Journal of Neuroscience Methods, 181, 235–240.CrossRefPubMed

Gehring, W. J., Affolter, M., & Burglin, T. (1994). Homeodomain proteins. Annual Review of Biochemistry, 63, 487–526.CrossRefPubMed

Guan, X. L., He, X., Ong, W. Y., Yeo, W. K., Shui, G., & Wenk, M. R. (2006). Non-targeted profiling of lipids during kainate-induced neuronal injury. The FASEB Journal, 20, 1152–1161.CrossRefPubMed

Haughey, N. J., Cutler, R. G., Tamara, A., McArthur, J. C., Vargas, D. L., Pardo, C. A., et al. (2004). Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia. Annals of Neurology, 55, 257–267.CrossRefPubMed

Haughey, N. J., Steiner, J., Nath, A., McArthur, J. C., Sacktor, N., Pardo, C., et al. (2008). Converging roles for sphingolipids and cell stress in the progression of neuro-AIDS. Frontiers in Bioscience, 13, 5120–5130.CrossRefPubMed

Imgrund, S., Hartmann, D., Farwanah, H., Eckhardt, M., Sandhoff, R., Degen, J., et al. (2009). Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and hepatocarcinomas. The Journal of Biological Chemistry, 284, 33549–33560.CrossRefPubMed

Jana, A., Hogan, E. L., & Pahan, K. (2009). Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death. Journal of the Neurological Sciences, 278, 5–15.CrossRefPubMed

Kroesen, B. J., Jacobs, S., Pettus, B. J., Sietsma, H., Kok, J. W., Hannun, Y. A., et al. (2003). BcR-induced apoptosis involves differential regulation of C16 and C24-ceramide formation and sphingolipid-dependent activation of the proteasome. The Journal of Biological Chemistry, 278, 14723–14731.CrossRefPubMed

Lahiri, S., & Futerman, A. H. (2007). The metabolism and function of sphingolipids and glycosphingolipids. Cellular and Molecular Life Sciences, 64, 2270–2284.CrossRefPubMed

Laviad, E. L., Albee, L., Pankova-Kholmyansky, I., Epstein, S., Park, H., Merrill, A. H., Jr, et al. (2008). Characterization of ceramide synthase 2: Tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate. The Journal of Biological Chemistry, 283, 5677–5684.CrossRefPubMed

Lee, S. J. (1991). Expression of growth/differentiation factor 1 in the nervous system: conservation of a bicistronic structure. Proceedings of the National Academy of Sciences of the United States of America, 88, 4250–4254.CrossRefPubMed

Levy, M., & Futerman, A. H. (2010). Mammalian ceramide synthases. IUBMB Life, 62, 347–356.CrossRefPubMed

Luberto, C., Kraveka, J. M., & Hannun, Y. A. (2002). Ceramide regulation of apoptosis versus differentiation: A walk on a fine line. Lessons from neurobiology. Neurochemical Research, 27, 609–617.CrossRefPubMed

Mesika, A., Ben-Dor, S., Laviad, E. L., & Futerman, A. H. (2007). A new functional motif in Hox domain-containing ceramide synthases: Identification of a novel region flanking the Hox and TLC domains essential for activity. The Journal of Biological Chemistry, 282, 27366–27373.CrossRefPubMed

Min, J., Mesika, A., Sivaguru, M., Van Veldhoven, P. P., Alexander, H., Futerman, A. H., et al. (2007). (Dihydro)ceramide synthase 1 regulated sensitivity to cisplatin is associated with the activation of p38 mitogen-activated protein kinase and is abrogated by sphingosine kinase 1. Molecular Cancer Research, 5, 801–812.CrossRefPubMed

Mitoma, J., Ito, M., Furuya, S., & Hirabayashi, Y. (1998). Bipotential roles of ceramide in the growth of hippocampal neurons: Promotion of cell survival and dendritic outgrowth in dose- and developmental stage-dependent manners. Journal of Neuroscience Research, 51, 712–722.CrossRefPubMed

Mizutani, Y., Mitsutake, S., Tsuji, K., Kihara, A., & Igarashi, Y. (2009). Ceramide biosynthesis in keratinocyte and its role in skin function. Biochimie, 91, 784–790.CrossRefPubMed

Morales, A., Lee, H., Goni, F. M., Kolesnick, R., & Fernandez-Checa, J. C. (2007). Sphingolipids and cell death. Apoptosis, 12, 923–939.CrossRefPubMed

O’Brien, J. S., & Sampson, E. L. (1965). Fatty acid and fatty aldehyde composition of the major brain lipids in normal human gray matter, white matter, and myelin. Journal of Lipid Research, 6, 545–551.PubMed

Pewzner-Jung, Y., Ben-Dor, S., & Futerman, A. H. (2006). When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?: Insights into the regulation of ceramide synthesis. The Journal of Biological Chemistry, 281, 25001–25005.CrossRefPubMed

Pinto, S. N., Silva, L. C., de Almeida, R. F., & Prieto, M. (2008). Membrane domain formation, interdigitation, and morphological alterations induced by the very long chain asymmetric C24:1 ceramide. Biophysical Journal, 95, 2867–2879.CrossRefPubMed

Rankin, C. T., Bunton, T., Lawler, A. M., & Lee, S. J. (2000). Regulation of left-right patterning in mice by growth/differentiation factor-1. Nature Genetics, 24, 262–265.CrossRefPubMed

Riebeling, C., Allegood, J. C., Wang, E., Merrill, A. H., Jr, & Futerman, A. H. (2003). Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors. The Journal of Biological Chemistry, 278, 43452–43459.CrossRefPubMed

Sastry, P. S. (1985). Lipids of nervous tissue: Composition and metabolism. Progress in Lipid Research, 24, 69–176.CrossRefPubMed

Schulz, A., Mousallem, T., Venkataramani, M., Persaud-Sawin, D. A., Zucker, A., Luberto, C., et al. (2006). The CLN9 protein, a regulator of dihydroceramide synthase. The Journal of Biological Chemistry, 281, 2784–2794.CrossRefPubMed

Schwarz, A., & Futerman, A. H. (1996). The localization of gangliosides in neurons of the central nervous system: The use of anti-ganglioside antibodies. Biochimica et Biophysica Acta, 1286, 247–267.PubMed

Schwarz, A., & Futerman, A. H. (1997). Distinct roles for ceramide and glucosylceramide at different stages of neuronal growth. Journal of Neuroscience, 17, 2929–2938.PubMed

Senkal, C. E., Ponnusamy, S., Bielawski, J., Hannun, Y. A., & Ogretmen, B. (2009). Antiapoptotic roles of ceramide-synthase-6-generated C16-ceramide via selective regulation of the ATF6/CHOP arm of ER-stress-response pathways. The FASEB Journal, 24, 296–308.CrossRefPubMed

Senkal, C. E., Ponnusamy, S., Rossi, M. J., Bialewski, J., Sinha, D., Jiang, J. C., et al. (2007). Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas. Molecular Cancer Therapeutics, 6, 712–722.CrossRefPubMed

Sot, J., Aranda, F. J., Collado, M. I., Goni, F. M., & Alonso, A. (2005). Different effects of long- and short-chain ceramides on the gel-fluid and lamellar-hexagonal transitions of phospholipids: A calorimetric, NMR, and X-ray diffraction study. Biophysical Journal, 88, 3368–3380.CrossRefPubMed

Spassieva, S. D., Mullen, T. D., Townsend, D. M., & Obeid, L. M. (2009). Disruption of ceramide synthesis by CerS2 down-regulation leads to autophagy and the unfolded protein response. Biochemical Journal, 424, 273–283.CrossRefPubMed

Sridevi, P., Alexander, H., Laviad, E. L., Min, J., Mesika, A., Hannink, M., et al. (2010). Stress-induced ER to Golgi translocation of ceramide synthase 1 is dependent on proteasomal processing. Experimental Cell Research, 316, 78–91.CrossRefPubMed

Sridevi, P., Alexander, H., Laviad, E. L., Pewzner-Jung, Y., Hannink, M., Futerman, A. H., et al. (2009). Ceramide synthase 1 is regulated by proteasomal mediated turnover. Biochimica et Biophysica Acta, 1793, 1218–1227.PubMed

van Ham, T. J., Thijssen, K. L., Breitling, R., Hofstra, R. M., Plasterk, R. H., & Nollen, E. A. (2008). C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genetics, 4, e1000027.CrossRefPubMed

van Zyl, R., Gieselmann, V., & Exckhardt, M. (2010). Elevated sulfatide levels in neurons cause lethal audiogenic seizures in mice. Journal of Neurochemistry, 112, 282–295.CrossRefPubMed

Vantaggiato, C., Redaelli, F., Falcone, S., Perrotta, C., Tonelli, A., Bondioni, S., et al. (2009). A novel CLN8 mutation in late-infantile-onset neuronal ceroid lipofuscinosis (LINCL) reveals aspects of CLN8 neurobiological function. Human Mutation, 30, 1104–1116.CrossRefPubMed

Venkataraman, K., Riebeling, C., Bodennec, J., Riezman, H., Allegood, J. C., Sullards, M. C., et al. (2002). Upstream of growth and differentiation factor 1 (uog1), a mammalian homolog of the yeast longevity assurance gene 1 (LAG1), regulates N-stearoyl-sphinganine (C18-(dihydro)ceramide) synthesis in a fumonisin B1-independent manner in mammalian cells. The Journal of Biological Chemistry, 277, 35642–35649.CrossRefPubMed

Wang, G., Silva, J., Dasgupta, S., & Bieberich, E. (2008). Long-chain ceramide is elevated in presenilin 1 (PS1M146 V) mouse brain and induces apoptosis in PS1 astrocytes. Glia, 56, 449–456.CrossRefPubMed

Yu, R. K., & Saito, M. (1989). Structure and localization of gangliosides. In R. U. Margolis & R. K. Margolis (Eds.), Neurobiology of glycoconjugates (pp. 1–42). Plenum Press.

Titel: The Role of the Ceramide Acyl Chain Length in Neurodegeneration: Involvement of Ceramide Synthases
verfasst von: Oshrit Ben-David
Anthony H. Futerman
Publikationsdatum: 01.12.2010
Verlag: Humana Press Inc
Erschienen in: NeuroMolecular Medicine / Ausgabe 4/2010
Print ISSN: 1535-1084
Elektronische ISSN: 1559-1174
DOI: https://doi.org/10.1007/s12017-010-8114-x

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2010

Sphingolipids in Neurodegeneration

Mammalian Neutral Sphingomyelinases: Regulation and Roles in Cell Signaling Responses

Sphingolipids in Multiple Sclerosis

Pathology and Current Treatment of Neurodegenerative Sphingolipidoses

Alterations of the Sphingolipid Pathway in Alzheimer’s Disease: New Biomarkers and Treatment Targets?